(株)医学生物学研究所の貸借残高情報
主市場 | 業種 | 証券コード/EDINET | 英名称 |
---|
東証JQS | 医薬品 | 4557/E00978 | - |
公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
---|
2020/09/25 | 日証協 | 222,121株 | -1.51% | 21,700株 | +301.85% | 212,069株 | +23.97% | 81,205株 | +316.39% |
2020/09/18 | 日証協 | 225,521株 | -5.84% | 5,400株 | -73.66% | 171,069株 | +4.19% | 19,502株 | +163.18% |
2020/09/11 | 日証協 | 239,521株 | +9.21% | 20,500株 | -68.41% | 164,182株 | +3.34% | 7,410株 | -28.78% |
2020/09/04 | 日証協 | 219,321株 | -3.48% | 64,900株 | +165.98% | 158,872株 | -2.63% | 10,405株 | +37.91% |
2020/08/28 | 日証協 | 227,221株 | +2.07% | 24,400株 | +177.27% | 163,167株 | +0.03% | 7,545株 | -26.82% |
2020/08/21 | 日証協 | 222,621株 | -8.13% | 8,800株 | -83.29% | 163,117株 | -7.22% | 10,310株 | +19% |
2020/08/14 | 日証協 | 242,321株 | +2.76% | 52,654株 | -24.18% | 175,817株 | +0.86% | 8,664株 | -74.17% |
2020/08/07 | 日証協 | 235,821株 | +1.34% | 69,447株 | -55.65% | 174,317株 | -7.86% | 33,546株 | -73.42% |
2020/07/22 | 日証協 | 124,921株 | +38.61% | 79,800株 | +1056.52% | 118,412株 | +32.14% | 45,900株 | +617.19% |
2020/07/17 | 日証協 | 90,121株 | -20.26% | 6,900株 | -83% | 89,612株 | -11.11% | 6,400株 | -76.4% |
2020/07/10 | 日証協 | 113,021株 | +43.03% | 40,600株 | -34.83% | 100,812株 | +21.46% | 27,115株 | -52.44% |
2020/07/03 | 日証協 | 79,021株 | -33.27% | 62,300株 | 0% | 82,997株 | +1.11% | 57,008株 | +28.93% |
2020/06/26 | 日証協 | 118,421株 | +41.11% | 62,300株 | +26.11% | 82,089株 | -2.48% | 44,215株 | +2.53% |
2020/06/12 | 日証協 | 78,821株 | -19.03% | 11,300株 | -56.54% | 93,684株 | -8.43% | 16,506株 | -68.93% |
2020/06/05 | 日証協 | 97,346株 | -14.34% | 26,000株 | -42.86% | 102,306株 | -7.13% | 53,132株 | -9.49% |
2020/05/29 | 日証協 | 113,646株 | +27.84% | 45,500株 | +758.49% | 110,155株 | +46.84% | 58,700株 | +337.73% |
2020/05/22 | 日証協 | 88,896株 | -10.47% | 5,300株 | -41.76% | 75,015株 | +5.98% | 13,410株 | -3.62% |
2020/05/15 | 日証協 | 99,296株 | -28.66% | 9,100株 | -80.96% | 70,782株 | -26.6% | 13,913株 | +50.61% |
2020/05/08 | 日証協 | 139,196株 | -36.29% | 47,800株 | -76.24% | 96,437株 | -35.34% | 9,238株 | -93.32% |
※株式分割は考慮していませんのでご注意ください。
Page Top